Pasit Phiasivongsa

Pasit Phiasivongsa, Ph.D.

Senior Vice President, Pharmaceutical Development and Manufacturing

Pasit joined Kronos Bio in December 2020 as Senior Vice President of Pharmaceutical Development. He has more than 20 years of drug development experience in the biopharmaceutical industry, overseeing manufacturing processes for novel medicines and advancing chemistry, manufacturing and controls (CMC) development programs through proof-of-concept validation to commercial production. Prior to Kronos Bio, Pasit was Senior Vice President, Technical Operations, at Principia Biopharma, a Sanofi company, where he led all CMC development, manufacturing and supply chain-related activities and built the technical operations organization. Prior to Principia, he was Vice President, Pharmaceutical Development, at Tobira Therapeutics (acquired by Allergan). Earlier in his career, he held positions in drug discovery, development and manufacturing at Dynavax Technologies; Onyx Pharmaceuticals, a subsidiary of Amgen; Proteolix, Inc. (acquired by Onyx Pharmaceuticals); Astex Pharmaceuticals (formerly SuperGen, Inc.); and Optimer Pharmaceuticals. He began his career in the biopharma industry as a research assistant at Cell Pathways, Inc. Pasit holds a B.S. in biochemistry and a Ph.D. in pharmaceutical and chemical sciences from the University of the Pacific.